Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
45
FOLD Quote, Financials, Valuation and Earnings
Last price:
$6.30
Seasonality move
:
3.26%
Day range:
$5.94 - $6.09
52-week range:
$5.51 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.42x
P/B ratio:
9.66x
Volume:
3.3M
Avg. volume:
5M
1-year change:
-44%
Market cap:
$1.9B
Revenue:
$528.3M
EPS (TTM):
-$0.09
Earnings Data
Next earnings date for FOLD
Aug 08
2025
Most recent earnings per share
-$0.07
Missed by $0.15
(May 1/2025)
Consensus Estimate
$0.08
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FOLD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $164.2M | -- | -- | $0.12 | -- |
| 08/08/2025 | Q2 | $146.7M | -- | -- | $0.04 | -- |
| 05/01/2025 | Q1 | $136.3M | $125.2M | -$0.07 | $0.08 | -$0.15 |
| 02/19/2025 | Q4 | $147.9M | $149.7M | $0.05 | $0.09 | -$0.04 |
| 11/06/2024 | Q3 | $135M | $141.5M | -$0.02 | $0.05 | -$0.07 |
| 08/08/2024 | Q2 | $121.2M | $126.7M | -$0.05 | $0.02 | -$0.07 |
| 05/09/2024 | Q1 | $111.2M | $110.4M | -$0.16 | -$0.03 | -$0.13 |
| 02/28/2024 | Q4 | $115M | $115.1M | -$0.11 | -$0.04 | -$0.07 |
| 11/08/2023 | Q3 | -- | -- | -$0.07 | -$0.08 | $0.01 |
| 08/08/2023 | Q2 | -- | -- | -$0.15 | -$0.11 | -$0.04 |
| 05/10/2023 | Q1 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
| 03/01/2023 | Q4 | -- | -- | -$0.19 | -$0.14 | -$0.05 |
| 11/07/2022 | Q3 | -- | -- | -$0.12 | -$0.19 | $0.07 |
| 08/04/2022 | Q2 | -- | -- | -$0.21 | -$0.22 | $0.01 |
| 05/09/2022 | Q1 | -- | -- | -$0.30 | -$0.29 | -$0.01 |
| 02/24/2022 | Q4 | -- | -- | -$0.29 | -$0.16 | -$0.13 |
| 11/09/2021 | Q3 | -- | -- | -$0.19 | -$0.18 | -$0.01 |
| 08/05/2021 | Q2 | -- | -- | -$0.19 | -$0.20 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | -$0.25 | -$0.26 | $0.01 |
| 03/01/2021 | Q4 | -- | -- | -$0.27 | -$0.22 | -$0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.25 | -$0.20 | -$0.05 |
| 08/10/2020 | Q2 | -- | -- | -$0.20 | -$0.26 | $0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.35 | -$0.25 | -$0.10 |
| 03/02/2020 | Q4 | -- | -- | -$0.35 | -$0.26 | -$0.09 |
| 11/11/2019 | Q3 | -- | -- | -$0.24 | -$0.32 | $0.08 |
| 08/08/2019 | Q2 | -- | -- | -$0.36 | -$0.34 | -$0.03 |
| 05/08/2019 | Q1 | -- | -- | -$0.56 | -$0.31 | -$0.25 |
| 02/28/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/05/2018 | Q3 | -- | -- | -$0.84 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.33 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.28 | -- | -- |
| 02/28/2018 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.69 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$0.34 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.39 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.40 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -$0.35 | -- | -- |
| 02/26/2016 | Q4 | -- | -- | -$0.35 | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -$0.32 | -- | -- |
Amicus Therapeutics Earnings Questions
-
How Much did Amicus Therapeutics Generate in Revenue Last Quarter?
Amicus Therapeutics reported $125.2M worth of top line sales in its most recent quarter.
-
Did Amicus Therapeutics Beat Earnings Last Quarter?
Amicus Therapeutics announced earnings per share of -$0.07 which represents a miss of analyst forecast a $0.08 per share.
-
Is Amicus Therapeutics Profitable?
Amicus Therapeutics reported $113.6M that represents $0.37 per share over the last quarter.
-
What is the Analyst Consensus for Amicus Therapeutics EPS Next Year?
Amicus Therapeutics's earnings are forecast to decrease from -$0.18 per share to $0.24 per share next year representing a decrease of -50.71%.
-
When is Amicus Therapeutics's Earnings Date?
Amicus Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
